Unpatentable Drugs and the Standards of… : DASH Story 2015-03-26
Story content
We are facing precisely this issue. We have "rediscovered" a molecule, first made in the 1930's, that has potent activity against pseudomonas aeruginosa. It was apparently never followed up as a potential drug. It was never patented, either for composition of matter or utility, and neither of these options would be possible today due the prior art. It could yet be a very important therapeutic agent. We are trying to find out what creative, alternative paths might be available to provide the economic incentive for drug development of molecules in this situation. The article is directly germane to understanding this issue and defining potential solutions.
Country
US